Beneficial Effect of Tolerogenic Dendritic Cells Pulsed with MOG Autoantigen in Experimental Autoimmune Encephalomyelitis

CNS Neuroscience and Therapeutics

Volumn 21, Issue 3, 2015, Pages 222-230

  Mansilla, María José ^a,b   Sellès Moreno, Carla ^a   Fàbregas Puig, Sara ^a,b   Amoedo, Joan ^a,b   Navarro Barriuso, Juan ^a,b   Teniente Serra, Aina ^a,b   Grau López, Laia ^a   Ramo Tello, Cristina ^a   Martínez Cáceres, Eva M ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Dendritic cells; Experimental autoimmune encephalomyelitis; Regulatory T cells; Tolerance; Vitamin D3

Indexed keywords

AUTOANTIGEN; COLECALCIFEROL; INTERLEUKIN 10; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE; IL10 PROTEIN, MOUSE; MOG PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CELL CULTURE; CELL THERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; DISEASE SEVERITY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T LYMPHOCYTE; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL MOTION; CELL TRANSPLANTATION; CULTURE TECHNIQUE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOLOGY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; SPLEEN; TRANSPLANTATION;

ANIMALS; AUTOANTIGENS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELL TRANSPLANTATION; CELLS, CULTURED; CHOLECALCIFEROL; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INTERLEUKIN-10; MICE, INBRED C57BL; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; SEVERITY OF ILLNESS INDEX; SPLEEN; T-LYMPHOCYTES, REGULATORY;

EID: 84923846328     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12342     Document Type: Article

References (26)

1. McFarland HF. Martin R Multiple sclerosis: A complicated picture of autoimmunity. Nat Immunol 2007;8:913-919.
2. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000;343:938-952.
3. Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 2010;162:1-11.
4. Van Brussel I, Lee WP, Rombouts M, et al. Tolerogenic dendritic cell vaccines to treat autoimmune diseases: Can the unattainable dream turn into reality? Autoimmun Rev 2014;13:138-150.
5. Raich-Regue D, Glancy M, Thomson AW. Regulatory dendritic cell therapy: From rodents to clinical application. Immunol Lett 2013;161:216-221.
6. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003;21:685-711.
7. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007;7:610-621.
8. Maldonado RA, von Andrian UH. How tolerogenic dendritic cells induce regulatory T cells. Adv Immunol 2010;108:111-165.
9. Thomson AW, Robbins PD. Tolerogenic dendritic cells for autoimmune disease and transplantation. Ann Rheum Dis 2008;67(Suppl 3):iii90-iii96.
10. Hilkens CM, Isaacs JD, Thomson AW. Development of dendritic cell-based immunotherapy for autoimmunity. Int Rev Immunol 2010;29:156-183.
11. Raïch-Regue D, Grau-Lopez L, Naranjo-Gomez M, et al. Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients. Eur J Immunol 2012;42:771-782.
12. Bland JM, Altman DG. Analysis of continuous data from small samples. BMJ 2009;338:a3166.
13. Zhou F, Ciric B, Zhang GX, Rostami A. Immune tolerance induced by intravenous transfer of immature dendritic cells via up-regulating numbers of suppressive IL-10(+) IFN-gamma(+)-producing CD4(+) T cells. Immunol Res 2013;56:1-8.
14. Iruretagoyena MI, Sepulveda SE, Lezana JP, et al. Inhibition of nuclear factor-kappa B enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis. J Pharmacol Exp Ther 2006;318:59-67.
15. Hu J, Wan Y. Tolerogenic dendritic cells and their potential applications. Immunology 2011;132:307-314.
16. Piemonti L, Monti P, Sironi M, et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000;164:4443-4451.
17. Ferreira GB, van Etten E, Verstuyf A, et al. 1, 25-Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo. Diabetes Metab Res Rev 2011;27:933-941.
18. Menges M, Rossner S, Voigtlander C, et al. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 2002;195:15-21.
19. Xiao BG, Wu XC, Yang JS, et al. Therapeutic potential of IFN-gamma-modified dendritic cells in acute and chronic experimental allergic encephalomyelitis. Int Immunol 2004;16:13-22.
20. Pettersson A, Ciumas C, Chirsky V, Link H, Huang YM, Xiao BG. Dendritic cells exposed to estrogen in vitro exhibit therapeutic effects in ongoing experimental allergic encephalomyelitis. J Neuroimmunol 2004;156:58-65.
21. Stoop JN, Harry RA, von Delwig A, Isaacs JD, Robinson JH, Hilkens CM. Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses. Arthritis Rheum 2010;62:3656-3665.
22. Farias AS, Spagnol GS, Bordeaux-Rego P, et al. Vitamin D3 induces IDO+ tolerogenic DCs and enhances Treg, reducing the severity of EAE. CNS Neurosci Ther 2013;19:269-277.
23. Yeste A, Nadeau M, Burns EJ, Weiner HL, Quintana FJ. Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2012;109:11270-11275.
24. Hauben E, Gregori S, Draghici E, et al. Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells. Blood 2008;112:1214-1222.
25. Giannoukakis N, Phillips B, Finegold D, Harnaha J, Trucco M. Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care 2011;34:2026-2032.
26. Moreau A, Varey E, Bouchet-Delbos L, Cuturi MC. Cell therapy using tolerogenic dendritic cells in transplantation. Transplant Res 2012;1:13.